Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Hdl Handle:
http://hdl.handle.net/10144/612817
Title:
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
Authors:
Mitnick, CD; Rodriguez, CA; Hatton, ML; Brigden, G; Cobelens, F; Grobusch, MP; Horsburgh, R; Lange, C; Lienhardt, C; Oren, E; Podewils, LJ; Seaworth, B; van den Hof, S; Daley, CL; Gebhard, AC; Wares, F
Journal:
PloS One
Abstract:
There are numerous challenges in delivering appropriate treatment for multidrug-resistant tuberculosis (MDR-TB) and the evidence base to guide those practices remains limited. We present the third updated Research Agenda for the programmatic management of drug-resistant TB (PMDT), assembled through a literature review and survey.
Publisher:
Public Library of Science
Issue Date:
31-May-2016
URI:
http://hdl.handle.net/10144/612817
DOI:
10.1371/journal.pone.0155968
PubMed ID:
27223622
Submitted date:
2016-05-31
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorMitnick, CDen
dc.contributor.authorRodriguez, CAen
dc.contributor.authorHatton, MLen
dc.contributor.authorBrigden, Gen
dc.contributor.authorCobelens, Fen
dc.contributor.authorGrobusch, MPen
dc.contributor.authorHorsburgh, Ren
dc.contributor.authorLange, Cen
dc.contributor.authorLienhardt, Cen
dc.contributor.authorOren, Een
dc.contributor.authorPodewils, LJen
dc.contributor.authorSeaworth, Ben
dc.contributor.authorvan den Hof, Sen
dc.contributor.authorDaley, CLen
dc.contributor.authorGebhard, ACen
dc.contributor.authorWares, Fen
dc.date.accessioned2016-06-13T16:11:47Zen
dc.date.available2016-06-13T16:11:47Zen
dc.date.issued2016-05-31en
dc.date.submitted2016-05-31en
dc.identifier.citationProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda. 2016, 11 (5):e0155968 PLoS ONEen
dc.identifier.issn1932-6203en
dc.identifier.pmid27223622en
dc.identifier.doi10.1371/journal.pone.0155968en
dc.identifier.urihttp://hdl.handle.net/10144/612817en
dc.description.abstractThere are numerous challenges in delivering appropriate treatment for multidrug-resistant tuberculosis (MDR-TB) and the evidence base to guide those practices remains limited. We present the third updated Research Agenda for the programmatic management of drug-resistant TB (PMDT), assembled through a literature review and survey.en
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.en
dc.identifier.journalPloS Oneen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.